Foresite Capital Opportunity Management V, LLC (CIK 1792207) reported 36 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-08-10). Recent activity: Buy LTGO (3.1M shares), Buy LTGO (445,320 shares), Buy LTGO (1.1M shares), Buy LTGO (742,201 shares), Buy LTGO (140,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-10 | Latigo Biotherapeutics, Inc. (LTGO) | 10% Owner | Buy | 3.1M | $0 |
| 2026-08-10 | Latigo Biotherapeutics, Inc. (LTGO) | 10% Owner | Buy | 445,320 | $0 |
| 2026-08-10 | Latigo Biotherapeutics, Inc. (LTGO) | 10% Owner | Buy | 1.1M | $0 |
| 2026-08-10 | Latigo Biotherapeutics, Inc. (LTGO) | 10% Owner | Buy | 742,201 | $0 |
| 2026-08-10 | Latigo Biotherapeutics, Inc. (LTGO) | 10% Owner | Buy | 140,000 | $2.5M |
| 2026-08-10 | Latigo Biotherapeutics, Inc. (LTGO) | 10% Owner | Buy | 195,776 | $0 |
| 2026-08-10 | Latigo Biotherapeutics, Inc. (LTGO) | 10% Owner | Buy | 3.1M | $0 |
| 2026-08-10 | Latigo Biotherapeutics, Inc. (LTGO) | 10% Owner | Buy | 296,880 | $0 |
| 2026-04-03 | ALUMIS INC. (ALMS) | 10% Owner | Sell | 1.2M | $0 |
| 2026-04-03 | ALUMIS INC. (ALMS) | 10% Owner | Buy | 1.1M | $0 |
| 2026-04-03 | ALUMIS INC. (ALMS) | 10% Owner | Sell | 1.1M | $0 |
| 2026-04-03 | ALUMIS INC. (ALMS) | 10% Owner | Buy | 680,486 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 1.3M | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 335,521 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 37,855 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 229,428 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 697,885 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 37,855 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 1,626 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 67,207 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 458,855 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 348,942 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 37,855 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 922 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 38,133 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-08-10